The Prediction of Sonographic features and BRAF Mutation for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: Reply.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26493695)

Published in World J Surg on March 01, 2016

Authors

Ning Qu1,2, Rong-liang Shi1,2, Ben Ma1,2, Yi Gao3,2, Yu Wang1,2, Qing-hai Ji4,5

Author Affiliations

1: Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
2: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
3: Department of Ultrasonography, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
4: Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. jonathan_qn@163.com.
5: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. jonathan_qn@163.com.

Articles cited by this

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA (2013) 5.71

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab (2009) 3.23

American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making. Thyroid (2015) 2.11

Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis. World J Surg (2015) 2.09

BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol (2012) 1.90

Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features. World J Surg (2013) 1.09

Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J Surg (2011) 1.09

The Significance of BRAF V600e Mutation and Preoperative Ultrasound for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma. World J Surg (2016) 1.07

BRAF(V600E) mutation analysis in papillary thyroid carcinoma: is it useful for all patients? World J Surg (2014) 1.00

Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study. World J Surg Oncol (2012) 0.93

Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays. Thyroid (2014) 0.92

American Thyroid Association statement on preoperative imaging for thyroid cancer surgery. Thyroid (2015) 0.88

BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis. Acta Cytol (2011) 0.82

BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles. AJR Am J Roentgenol (2012) 0.81

Clinical application of molecular testing of fine-needle aspiration specimens in thyroid nodules. Otolaryngol Clin North Am (2014) 0.80

Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation. Medicine (Baltimore) (2015) 0.78

BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol (2013) 0.77